“…Han et al6, 7 have reported the synthesis, characterization and bioactivity of poly(DHP‐ alt‐ MA) and its derivatives, with different substituents (e.g., acetoxy, methoxy, ethoxy, methoxycarbonyl, formyl, acetoxymethyl, and tosyloxymethyl groups, as well as guanine derivatives) in the 2‐position of pyran ring of the copolymer backbone. These pyran‐containing copolymers with a high density of carboxylic acid functionality as the polynucleotide analogues exhibit antitumor activities in in vitro , which were found to have higher activities against the tumor cells (B16 and 3LL) than those of their acyclic analogues, especially alternating cyclocopolymer of divinyl ether with MA ( M n = 5500 g/mol and M w / M n = 1.3), whose biological activities have well been reported 8–10. It was found that poly(DHP‐ alt ‐MA) and its derivatives, which comprise different substituents (e.g., acetoxy, alkoxy, methoxycarbonyl, formyl, and tosyloxymethyl groups) in the 2‐position of the tetrahydropyran ring of the copolymer backbone, have higher antitumor activity against the selective tumor cells in vitro and in vivo 6.…”